Dixestivo

2014

1. "very early" intrahepatic cholangiocarcinoma in cirrhotic patients: Should liver transplantation be reconsidered in these patients?

   American Journal of Transplantation, Vol. 14, Núm. 3, pp. 660-667

2. 256 Is Fecal Calprotectin (FC) a Useful Tool for Screening MR-Enterography in Inflammatory Small Bowel Crohn's Disease (CD)?

   Gastroenterology, Vol. 146, Núm. 5, pp. S-61

3. A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis

   Human molecular genetics, Vol. 23, Núm. 25, pp. 6927-6934

4. A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer

   Human Genetics, Vol. 133, Núm. 5, pp. 525-534

5. Biosimilares : ¿qué son?, ¿para qué sirven?

   Inflamatoria: Revista oficial del grupo EIGA, Núm. 8, pp. 2-5

6. Characteristics of adenomas detected by fecal immunochemical test in colorectal cancer screening

   Cancer Epidemiology Biomarkers and Prevention, Vol. 23, Núm. 9, pp. 1884-1892

7. Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)

   Journal of Crohn's and Colitis, Vol. 8, Núm. 1, pp. 5-18

8. Consulta telemática realizada por Enfermería en pacientes con enfermedad inflamatoria intestinal: valoración de su capacidad resolutiva y costes

   Enfermería clínica, Vol. 24, Núm. 2, pp. 102-110

9. Contrast-enhanced harmonic endoscopic ultrasound imaging: Basic principles, present situation and future perspectives

   World Journal of Gastroenterology, Vol. 20, Núm. 42, pp. 15549-15563

10. Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients

    Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria, Vol. 38, Núm. 5, pp. 418-429

11. Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening

    United European Gastroenterology Journal, Vol. 2, Núm. 6, pp. 522-529

12. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: Comparison with NICE and SIGN referral criteria

    Colorectal Disease, Vol. 16, Núm. 8

13. Drug trough levels and primary nonresponse to antiTNF therapy in moderate-severe Crohn disease

    Gastroenterology, Vol. 146, Núm. Suppl. 1, pp. 247

14. EUS-guided choledochoduodenostomy with lumen-apposing metal stent after failed rendezvous in synchronous malignant biliary and gastric outlet obstruction (with video)

    Gastrointestinal Endoscopy, Vol. 80, Núm. 2, pp. 342-344

15. Early and/or immediately full caloric diet versus standard refeeding in mild acute pancreatitis: A randomized open-label trial

    Pancreatology, Vol. 14, Núm. 3, pp. 167-173

16. East-West gradient in the incidence of inflammatory bowel disease in Europe: The ECCO-EpiCom inception cohort

    Gut, Vol. 63, Núm. 4, pp. 588-597

17. Effect of oral anticoagulants on the outcome of faecal immunochemical test

    British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337

18. Endoscopic submucosal dissection

    Endoscopy, Vol. 46, Núm. 4, pp. 361-370

19. Endoscopic ultrasound

    Endoscopy, Vol. 46, Núm. 4, pp. 337-341

20. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe - An ECCO-EpiCom study

    Journal of Crohn's and Colitis, Vol. 8, Núm. 7, pp. 607-616